Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fraga

Showing results (361-370 of 396) with videos related to

Pageof 40
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2022
Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemiaRosa Vargas-Poussou, Felix Claverie-Martin, Caroline Prot-Bertoye, et al.
Acta Tropica|February 15, 2022
Screening organic repellent compounds against Lutzomyia longipalpis (Diptera: Psychodidae) present in plant essential oils: Bioassay plus an in silico approachTiago F Mota, Caliene M de A Silva, Maurício Dos S Conceição, et al.
Plos One|June 19, 2014
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic painCleverton K F Lima, Rafael M Silva, Renata B Lacerda, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|December 16, 2014
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II InhibitorsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
European Journal of Medicinal Chemistry|May 10, 2011
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking propertiesLuiz A S Romeiro, Marcos da Silva Ferreira, Leandro L da Silva, et al.
The Pediatric Infectious Disease Journal|August 5, 2000
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study GroupX Carbonell-Estrany, J Quero, G Bustos, et al.
Cancers|January 21, 2022
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N C Boyd, Mahsoem Ali, Laura Kam, et al.
Pharmaceuticals (Basel, Switzerland)|November 4, 2018
Design, Synthesis, Experimental and Theoretical Characterization of a New Multitarget 2-Thienyl-<i>N</i>-Acylhydrazone DerivativeIsadora T S Bastos, Pedro de Sena M Pinheiro, Fanny N Costa, et al.
British Journal of Pharmacology|April 20, 2010
LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligationJ L M Tributino, M L H Santos, C M Mesquita, et al.
JAMA Network Open|August 28, 2023
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N C Boyd, Mahsoem Ali, Annalisa Comandatore, et al.
Pageof 40

Showing results (361-370 of 396) with videos related to

Sort By:
Pageof 40
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2022
Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemiaRosa Vargas-Poussou, Felix Claverie-Martin, Caroline Prot-Bertoye, et al.
Acta Tropica|February 15, 2022
Screening organic repellent compounds against Lutzomyia longipalpis (Diptera: Psychodidae) present in plant essential oils: Bioassay plus an in silico approachTiago F Mota, Caliene M de A Silva, Maurício Dos S Conceição, et al.
Plos One|June 19, 2014
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic painCleverton K F Lima, Rafael M Silva, Renata B Lacerda, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|December 16, 2014
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II InhibitorsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
European Journal of Medicinal Chemistry|May 10, 2011
Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking propertiesLuiz A S Romeiro, Marcos da Silva Ferreira, Leandro L da Silva, et al.
The Pediatric Infectious Disease Journal|August 5, 2000
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study GroupX Carbonell-Estrany, J Quero, G Bustos, et al.
Cancers|January 21, 2022
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel ApproachLenka N C Boyd, Mahsoem Ali, Laura Kam, et al.
Pharmaceuticals (Basel, Switzerland)|November 4, 2018
Design, Synthesis, Experimental and Theoretical Characterization of a New Multitarget 2-Thienyl-<i>N</i>-Acylhydrazone DerivativeIsadora T S Bastos, Pedro de Sena M Pinheiro, Fanny N Costa, et al.
British Journal of Pharmacology|April 20, 2010
LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligationJ L M Tributino, M L H Santos, C M Mesquita, et al.
JAMA Network Open|August 28, 2023
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N C Boyd, Mahsoem Ali, Annalisa Comandatore, et al.
Pageof 40